Data / Research funding / Maryland / Emocha Mobile Health, Inc.
Emocha Mobile Health, Inc.: 4 NIH awards ($6.3M), fiscal years 2021 to 2026
Emocha Mobile Health, Inc. in Owings Mills, MD is funded under 4 NIH awards ($6.3M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- FHWGEP6NNLG1
- State
- Maryland
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,964,306 | September 30, 2020 | July 31, 2027 | SEIGUER, SEBASTIAN | reporter.nih.gov |
| ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,904,006 | September 15, 2023 | August 31, 2026 | SEIGUER, SEBASTIAN | reporter.nih.gov |
| Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,676,046 | April 1, 2023 | March 31, 2026 | SEIGUER, SEBASTIAN | reporter.nih.gov |
| Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $728,484 | September 19, 2019 | August 31, 2023 | SEIGUER, SEBASTIAN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 2 | $1,299,682 | 0 | $0 |
| 2024 | 3 | $2,108,702 | 0 | $0 |
| 2023 | 3 | $2,135,974 | 0 | $0 |
| 2021 | 1 | $728,484 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) | RFA-DK-27-125 | NIH | 93.847 | November 6, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) | RFA-DK-27-112 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) | RFA-DK-27-139 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) | PAR-24-089 | NIH | 93.279 | November 13, 2026 | $750,000 | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.279 | November 16, 2026 | $50,000 | Same assistance listing 93.279 as 1 award here |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) | RFA-DK-27-122 | NIH | 93.847 | November 17, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.279 | November 18, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.279 | November 18, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.279 | November 24, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.847 | December 4, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.847 | January 5, 2027 | Not listed | Same assistance listing 93.847 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.837 | January 7, 2027 | $375,000 | Same assistance listing 93.837 as 1 award here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.279 | January 7, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.847 | January 7, 2027 | Not listed | Same assistance listing 93.847 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.847 | January 15, 2027 | $350,000 | Same assistance listing 93.847 as 1 award here |
| HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) | RFA-DA-28-011 | NIH | 93.279 | January 26, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) | RFA-DA-28-012 | NIH | 93.279 | January 26, 2027 | Not listed | Same assistance listing 93.279 as 1 award here |
Topics of its NIH awards
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.